Related Experiment Video
Updated: Apr 29, 2026
04:10
Author Spotlight: Exploring Venous Waveforms for Non-Invasive Respiratory Monitoring in Pigs
Published on: March 8, 2024
2.0K
Emerging trends in management of propionic acidemia
1Central Aseer Hospital Abha, Kingdom of Saudi Arabia.
Arquivos Brasileiros De Endocrinologia E Metabologia
|May 28, 2014
Summary
Effective management of propionic acidemia (PA) metabolic crises involves protein restriction and supportive care. Long-term treatment focuses on nutrition, supplements like L-carnitine, and regular monitoring to prevent decompensation.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Propionic acidemia (PA) is a rare genetic metabolic disorder.
- PA disrupts the normal breakdown of proteins and certain fats, leading to toxic metabolite buildup.
Purpose of the Study:
- To evaluate therapeutic agents for acute metabolic crises in PA patients.
- To assess long-term management strategies for individuals with propionic acidemia.
Main Methods:
- Retrospective analysis of medical records from 30 PA patients.
- Evaluation of treatments administered during 141 hospital admissions.
Main Results:
- Metabolic crises frequently involved hyperammonemia, managed with IV fluids, dextrose, and protein restriction.
- Intensive care, mechanical ventilation, and dialysis were employed in severe cases.
- Common rescue therapies included L-carnitine, sodium bicarbonate, and sodium benzoate; nutritional support was universal.
Conclusions:
- Aggressive management of acute crises is crucial, focusing on protein restriction, stabilization, and metabolite removal.
- Adequate nutrition, risk minimization for decompensation, and further therapeutic advancements are vital for improving PA patient outcomes.
Related Concept Videos
01:24Cystic Fibrosis: Management
655
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
655
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
409
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
409
01:24Diagnosing Acidosis and Alkalosis
1.6K
Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
1.6K
01:29Chronic Pancreatitis II: Collaborative Care
561
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
561
01:20Inborn Errors of Metabolism
1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
960
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
960